1Hundal HS, Ramlal T, Reyes R, et al. Mechanism by which metformin reduces glucose production in type 2 diabetes[J]. Diabetes, 2000, 49: 2063-2069.
2De Aguiar LG, Bahia LR, Villela N, et al. Metformin improves endothelial vascular reactivity in first-degree relatives of type 2 diabetic patients with metabolic syndrome and normal glucose tolerance[J]. Diabetes Care, 2006, 29(5): 1083-1089.
3Petersen JS, DiBona GE Acute sympathoinhibitory actions of metformin in spontaneously hypertensive rats[J]. Hypertension, 1996, 27(3 Pt 2):619-625.
4UK Prospective Diabetes study (UKPDS) Group. Effect of intensive bloodglucose control with metformin on complications in overweight patients with type 2 diabetes CUKPDS 34)[J].Lancet, 1998, 352: 854-865.
5StrattonIM, Adler AI, Nell HA, et al. Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35):prospective observational study. Br Med J, 2000, 321: 405-412.
6Cullen E, Liao J Lukacsko P, et al. Pharmacokinetics and dose proportionality of extended-release metformin following administration of 1000, 1500, 2000 and 2500 mg in healthy volunteers[]]. Biopharmaceutics and Drug Disposition, 2004, 25(6): 261-264.
7Cusi K, Consoli A, DeFronzo RA. Metabolic effects of metformin on glucose and lactate metabolism in noninsulin dependent diabetes mellitus[J]. J Clin Endocrinol Metab, 1996, 81 ( 11): 4059-4067.
9Bodmer M,Meier C,Kr henbühl S,Jick SS,et al.Metformin,sulfonylureas,or other antidiabetes drugs and the risk of lactic acidosis or hypoglycemia:a nested case-control analysis[J].Diabetes Care,2008Nov,31(11):2086-91.
10Nathan DM,Buse JB,Davidson MB,et al.Management of hyperglycaemia in type 2 diabetes:a consensus algorithm for the initiation and adjustment of therapy.A consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes[J].Diabetologia,2006 Aug,49(8):1711-21.
